#15
|
|||
|
|||
Ñìåñè íà îñíîâå ÷àñòè÷íî ãèäðîëèçîâàííûõ (ðàñùåïëåííûõ) áåëêîâ: òåðàïåâòè÷åñêèé ïîòåíöèàë ïðè ÀÄ(ïðîôèëàêòèêà ó äåòåé ñ âûñîêèì ðèñêîì ÀÄ, òàêæå ïðè ëåãêèõ è óìåðåííûõ ïðîÿâëåíèÿõ ÀÄ)
Partially hydrolyzed cow’s milk formula has a therapeutic effect on the infants with mild to moderate atopic dermatitis: a randomized, double-blind study [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] The allergy-preventing effect of partially hydrolyzed cow’s milk formula (phCMF) in infants at high risk of atopic dermatitis (AD) has been demonstrated in many studies. However, the therapeutic potential of phCMF in treating the infants with AD has not been reported. We sought to assess such therapeutic efficacy of phCMF in infants with mild to moderate AD. Conclusion: This study suggests a novel therapeutic effect of phCMF in treating infants with mild to moderate AD during the first 6 months of their life without affecting their nutritional status. |